Location matters: Overlooked ethnic-geographic effect in China and Austria on propofol/cisatracurium sex differences among a population pharmacokinetic/pharmacodynamic (PopPK/PD) covariate analysis in men, women, and one transgender subject.
bispectral index
electroencephalography
gender
mechanomyography
pharmacokinetic-pharmacodynamic
sex
Journal
Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
21
11
2020
accepted:
26
05
2021
pubmed:
30
5
2021
medline:
18
1
2022
entrez:
29
5
2021
Statut:
ppublish
Résumé
A quick literature search using "sex/gender" vs. the commonly used hypnotic propofol or neuromuscular-blocking agent cisatracurium will reveal numerous contradictory sex difference publications depending on the ethnic-geographic location of where these studies were conducted. We induced anesthesia with cisatracurium besylate (GlaxoSmithKline) 100 μg kg
Substances chimiques
Anesthetics, Intravenous
0
Atracurium
2GQ1IRY63P
cisatracurium
QX62KLI41N
Propofol
YI7VU623SF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
182-198Informations de copyright
© 2021 Société Française de Pharmacologie et de Thérapeutique.
Références
Kelley DB. The genesis of male and female brains. Trends Neurosci. 1986;9:499-502.
Pleym H, Spigset O, Kharasch ED, Dale O. Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand. 2003;47:241-259.
Adamus M, Gabrhelik T, Marek O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. Eur J Anesthesiol. 2008;25:589-595.
Schmith VD, Fiedler-Kelly J, Phillips L, Grasela TH Jr. Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharm Res. 1997;14:91-97.
Shi HJ, Liang QB. Impact of gender on the dose-effect relationship of cisatracurium. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:1287-1289.
Gan TJ, Glass PS, Sigl J et al. Women emerge from general anesthesia with propofol/alfentanil/nitrous oxide faster than men. Anesthesiology. 1999;90:1283-1287.
Apfelbaum JL, Grasela TH, Hug CC Jr et al. The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakening. Anesth Analg. 1993;77:S10-S14.
Myles PS, McLeod AD, Hunt JO, Fletcher H. Sex differences in speed of emergence and quality of recovery after anaesthesia: cohort study. BMJ. 2001;322:710-711.
Bossuyt PM, Reitsma JB, Bruns DE et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chemy. 2003;49:7-18.
Dahaba AA, Bornemann H, Hopfgartner E et al. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia. Br J Anaesth. 2011;108:602-606.
Chernik DA, Gillings D, Laine H et al. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244-251.
Dahaba AA, Lischnig U, Kronthaler R et al. Bispectral-index-guided versus clinically guided remifentanil/propofol analgesia/sedation for interventional radiological procedures: an observer-blinded randomized study. Anesth Analg. 2006;103:378-384.
Rowaan CJ, Vandenbrom RHG, Wierda JMKH. The Relaxometer: a complete and comprehensive computer-controlled neuromuscular transmission measurement system developed for clinical research on muscle relaxants. J Clin Monit. 1993;9:38-44.
Dahaba AA, Prax N, Gaube W, Gries M, Rehak PH, Metzler H. Haemodynamic and catecholamine stress responses to the Laryngeal Tube-Suction Airway and the Proseal Laryngeal Mask Airway. Anaesthesia. 2006;61:330-334.
Farenc C, Audran M, Lefrant JY, Mazerm I, Bressolle F. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. J Chromatogr B Biomed Sci Appl. 1999;724:117-126.
Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57:1539-1558.
Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects. J of Pharmacokinet Biopharm. 1992;20:511-528.
Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75:85-94.
Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13:143-151.
Kodaka M, Johansen JW, Sebel PS. The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth Analg. 2005;101:377-381.
Fisher DM, Fahey MR, Cronnelly R, Miller RD. Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques. Anesthesiology. 1982;57:309-310.
Jung JA, Choi BM, Cho SH et al. Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under total intravenous anaesthesia. Br J Anaesth. 2010;104:563-576.
Høymork SC, Raeder J, Grimsmo B, Steen PA. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand. 2000;44:1138-1144.
Hoymork SC, Raeder J, Grimsmo B, Steen PA. Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. Br J Anaesth. 2003;91:773-780.
Friis-Hansen B. Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. Paediatrics. 1971;47(Suppl 2):264+.
Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res. 1972;5:411-459.
Holford NH, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981;6:429-453.
Chatelut E. Population approaches in paediatrics. Fundam Clin Pharmacol. 2008;22:575-578.
Delavenne X, Laporte S, Demasles S et al. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. Fundam Clin Pharmacol. 2009;23:127-135.
Bourguignon L, Ducher M, Matanza D et al. The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study. Fundam Clin Pharmacol. 2011;26:279-285.
Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. Anesthesiology. 1993;78:657-665.
Convertino VA. Gender differences in autonomic functions associated with blood pressure regulation. Am J Physiol. 1998;275:1909-1920.
Hiraoka H, Yamamoto K, Miyoshi S et al. Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. Br J Clin Pharmacol. 2005;60:176-182.
Absalom AR, Mani V, De Smet T, Struys MMRF. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. Br J Anaesth. 2009;103:26-37.